Journal article · 2025
THE ROLE OF PHARMACOGENOMICS IN OPTIMIZING DRUG THERAPY AND REDUCING ADVERSE REACTIONS
Journal of Pharmacology Genetics and Molecular Biology · Published 1 June 2025
In brief
“THE ROLE OF PHARMACOGENOMICS IN OPTIMIZING DRUG THERAPY AND REDUCING ADVERSE REACTIONS” is a 2025 journal article by kanchan Paswan and 6 co-authors, published in Journal of Pharmacology Genetics and Molecular Biology. OpenAlex counts 9 citations as of 21 November 2026, which puts it in the top 8% of works published in 2025 by citations. The publisher's version is not open access, and OpenAlex records no free legal copy.
- Citations
- 9
- Most cited in
- 2026 (7)
- Field-weighted impact
- 4.08
- Authors
- 7
Abstract
Pharmacogenomics is a fast-moving discipline that examines the intricate relationship between a patient's genetic profile and his/her response to drugs, paving the way for tailored medicine. Through the identification of genetic differences affecting drug metabolism, efficacy, and susceptibility to side effects, pharmacogenomics facilitates individualized drug therapy, ensuring maximum treatment efficacy while reducing the risks of… Read the full abstract at the publisher.
Excerpt. This paper is not open access.
Cite this paper
Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.
APA 7
Paswan, K., Anjum, N., Bhulaxmi, Sahu, B., Deshmukh, D., Kasar, I., & Deshmukh, N. (2025). THE ROLE OF PHARMACOGENOMICS IN OPTIMIZING DRUG THERAPY AND REDUCING ADVERSE REACTIONS. Journal of Pharmacology Genetics and Molecular Biology. https://jpgmb.com/index/article/view/13
MLA 9
Paswan, kanchan, et al. “THE ROLE OF PHARMACOGENOMICS IN OPTIMIZING DRUG THERAPY AND REDUCING ADVERSE REACTIONS.” Journal of Pharmacology Genetics and Molecular Biology, 2025. https://jpgmb.com/index/article/view/13.
Chicago
Paswan, kanchan, Nisar Anjum, Bhulaxmi, Bholenath Sahu, Dorendra Deshmukh, Isha Kasar, and Neeraj Deshmukh. 2025. “THE ROLE OF PHARMACOGENOMICS IN OPTIMIZING DRUG THERAPY AND REDUCING ADVERSE REACTIONS.” Journal of Pharmacology Genetics and Molecular Biology. https://jpgmb.com/index/article/view/13.
Harvard
Paswan, K. et al. (2025) ‘THE ROLE OF PHARMACOGENOMICS IN OPTIMIZING DRUG THERAPY AND REDUCING ADVERSE REACTIONS’, Journal of Pharmacology Genetics and Molecular Biology. Available at: https://jpgmb.com/index/article/view/13.
IEEE
K. Paswan et al., “THE ROLE OF PHARMACOGENOMICS IN OPTIMIZING DRUG THERAPY AND REDUCING ADVERSE REACTIONS,” Journal of Pharmacology Genetics and Molecular Biology, 2025.
BibTeX
@article{paswan2025role,
title = {{THE ROLE OF PHARMACOGENOMICS IN OPTIMIZING DRUG THERAPY AND REDUCING ADVERSE REACTIONS}},
author = {Paswan, kanchan and Anjum, Nisar and Bhulaxmi and Sahu, Bholenath and Deshmukh, Dorendra and Kasar, Isha and Deshmukh, Neeraj},
journal = {Journal of Pharmacology Genetics and Molecular Biology},
year = {2025},
url = {https://jpgmb.com/index/article/view/13}
}
Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)
Topic and keywords
Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Pharmacogenetics and Drug Metabolism
- pharmacogenomics
- precision medicine
- individualized drug therapy
- adverse drug reactions
- pharmacogenomic biomarkers
- genetic testing
- drug metabolism
- polygenic risk score
Work with this paper
Most-cited papers in Pharmacology, Toxicology and Pharmaceutics
- AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreadingOleg Trott, Arthur J. Olson · Journal of Computational Chemistry · 2009 · 39,860 citations
- AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibilityGarrett M. Morris, Ruth Huey, William Lindstrom and 4 more · Journal of Computational Chemistry · 2009 · 26,508 citations
- Development and testing of a general amber force fieldJunmei Wang, Romain M. Wolf, James W. Caldwell and 2 more · Journal of Computational Chemistry · 2004 · 20,080 citations
- Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings 1PII of original article: S0169-409X(96)00423-1. The article was originally published in Advanced Drug Delivery Reviews 23 (1997) 3–25. 1Christopher A. Lipinski, Franco Lombardo, Beryl W. Dominy and 1 more · Advanced Drug Delivery Reviews · 2001 · 19,638 citations
- SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small moleculesAntoine Daina, Olivier Alain Michielin, Vincent Zoete · Scientific Reports · 2017 · 19,557 citations
All highly cited Pharmacology, Toxicology and Pharmaceutics papers
Questions about this paper
How do I cite this paper in APA style?
Paswan, K., Anjum, N., Bhulaxmi, Sahu, B., Deshmukh, D., Kasar, I., & Deshmukh, N. (2025). THE ROLE OF PHARMACOGENOMICS IN OPTIMIZING DRUG THERAPY AND REDUCING ADVERSE REACTIONS. Journal of Pharmacology Genetics and Molecular Biology. https://jpgmb.com/index/article/view/13
How many times has this paper been cited?
9 times, according to OpenAlex on 21 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.
Is this paper free to read?
OpenAlex records no free legal copy. Check your library's access, the authors' pages or a repository, or ask the corresponding author for a copy.
Who wrote this paper?
kanchan Paswan, Nisar Anjum, Bhulaxmi, Bholenath Sahu, Dorendra Deshmukh, Isha Kasar, Neeraj Deshmukh.
Bibliographic data from OpenAlex (CC0), last checked 21 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.